Skip to main content
OpenTrials

Clinical trial condition

End-stage Liver Disease (ESLD)

Explore clinical trials studying End-stage Liver Disease (ESLD). Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

End-stage Liver Disease (ESLD) trial results

Recruiting

Restrictive Fluid Management In Liver Transplantation (REFIL)

NCT07695363

Conditions
Digestive System Diseases, End Stage Liver Disease, End-stage Liver Disease (ESLD), +4 more
Locations
  • Vancouver General Hospital (VGH) Vancouver, British Columbia, Canada
  • London Health Sciences Centre (LHSC) London, Ontario, Canada
  • Centre hospitalier de l'Université de Montréal (CHUM) Montreal, Quebec, Canada
  • McGill University Health Centre (MUHC) Montreal, Quebec, Canada
View Trial Details
Recruiting

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

NCT06823713

Conditions
Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +24 more
Locations
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
  • Hospital Universitario Reina Sofía Córdoba, Spain
  • Hospital General Universitario Gregorio Marañon Madrid, Spain
  • Hospital Universitario Ramón y Cajal Madrid, Spain
View all 14 locations
View Trial Details
Active, Not Recruiting

Restrictive Fluid Management In Liver Transplantation (REFIL) - Pilot

NCT05647733

Conditions
Digestive System Diseases, End Stage Liver Disease, End-stage Liver Disease (ESLD), +4 more
Locations
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Centre Hospitalier de l'Université de Montréal (CHUM) Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details

Related conditions